Plunkett Research Online: Compugen Ltd

COMPUGEN LTD (CGEN:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology.....



Compugen Ltd
Ticker: CGEN
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 972 37658585
Fax: 972 37658555
Address: 26 Harokmim Street
Building D, Azrieli Center
Holon, 5885849 Israel

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drug Discovery
Biotechnology Databases & Diagnostics
Agricultural Biotechnology
Bioinformatics Platform
Contacts Description
Anat Cohen-DayagCEO/Director/President
Alberto SessaCFO
See More
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology.....See More See More

Auditor: Kost, Forer, Gabbay & Kasierer
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
COM701
COM902
Compugen USA
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: